filmov
tv
Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results
Показать описание
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBCTV
Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result
Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine
Eli Lilly CEO David Ricks on GLP-1 and obesity drugs
Eli Lilly CEO David Ricks breaks down second-quarter earnings and drug pipeline
Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product
Eli Lilly CEO David Ricks on positive Alzheimer's drug trial data
Dave Ricks, CEO of Eli Lilly | The All-In Interview
Eli Lilly’s CEO David Ricks delves into the drivers of the healthcare industry
Eli Lilly CEO on Fighting Obesity, Developing New Drugs
Eli Lilly CEO David Ricks on coronavirus treatment developments (Full Stream 12/15)
Eli Lilly CEO on slashing insulin prices, approval timelines for weight-loss and Alzheimer's dr...
Eli Lilly CEO David Ricks explains how the company’s new covid-19 therapies help patients
Eli Lilly CEO David Ricks on the end of antibody study in hospitalized patients
Facing Forward: Eli Lilly CEO David Ricks on COVID-19 treatments
Watch CNBC's full interview with Eli Lilly CEO David Ricks
Footprints: Dave Ricks
India is an emerging superpower economically: Eli Lilly CEO David Ricks
Eli Lilly CEO talks expanding innovation past obesity drugs
David Ricks, Chairman and CEO, Eli Lilly and Company
President & CEO of Lilly Dave Ricks Talks Why D and I
Eli Lilly CEO David Ricks on Q2 results: Seeing unbelievable demand for Zepbound and Mounjaro
Eli Lilly CEO Ricks on Sales Forecast, Alzheimer's Drug
Eli Lilly CEO discusses FDA's approval of Biogen's new Alzheimer's drug
I get stories every day from patients about how Mounjaro is benefiting their lives: Eli Lilly CEO
Комментарии